# Evaluate The Efficacy and Safety Of Pregabalin In Prevention, Reduction of Oxaliplatin-Induced Painful Neuropathy

> **NCT01450163** · PHASE3 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 200 (actual)

## Conditions studied

- Pain
- Neuropathic Pain
- Polyneuropathy

## Interventions

- **DRUG:** Pregabalin, Oxaliplatin
- **DRUG:** Placebo , Oxaliplatin

## Key facts

- **NCT ID:** NCT01450163
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-10
- **Final completion:** 2014-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2017-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01450163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01450163, "Evaluate The Efficacy and Safety Of Pregabalin In Prevention, Reduction of Oxaliplatin-Induced Painful Neuropathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01450163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*